Approval · Notice of Compliance 16352 · 2014
GAZYVA: Notice of Compliance 16352
Issued November 25, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16352
- Date
- November 25, 2014
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GAZYVA | 02434806 | Marketed |
Medicinal ingredients
- OBINUTUZUMAB 25 MG per ML